A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia

Sleep Medicine

Volumn 1, Issue 1, 2000, Pages 41-49

  Walsh, James K ^a,b   Vogel, Gerald W ^c   Scharf, Martin ^d   Erman, Milton ^e   William Erwin, C ^f   Schweitzer, Paula K ^a   Mangano, Richard M ^g   Roth, Thomas ^h  

^a ST LUKE S HOSPITAL   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Sleep Research Laboratory   (United States)

^d Ctr for Research in Sleep Disorders   (United States)

^e Pacific Sleep Medicine Services   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g WYETH AYERST RESEARCH   (United States)

^h HENRY FORD HOSPITAL   (United States)

Author keywords

Efficacy; Polysomnography; Primary insomnia; Tolerance; Zaleplon

Indexed keywords

EID: 0002166750     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(99)00006-4     Document Type: Article

References (19)

1. Beer B., Clody D.E., Mangano R., et al. A review of the preclinical development of zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia. CNS Drug Rev. 3:1997;207-224.
2. Walsh J.K., Fry J., Erwin C.W., Scharf M., et al. Efficacy and safety of 14-day administration of zaleplon 5 mg and 10 mg for the treatment of primary insomnia. Clin Drug Invest. 16:1998;347-354.
3. Ancoli-Israel S., Walsh J.K., Mangano RM, Fujimori M. Zaleplon, a novel non-benzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects. Prim Care Companion J Clin Psychiat. 1:1999;114-120.
4. Hedner J., Emilien G., Salinas E. Improvement in sleep latency and sleep quality with zaleplon in elderly patients with primary insomnia. J Sleep Res. 7:(Suppl 2):1998;115.
5. Erwin C.W. Zaleplon effectively and safely treats chronic insomnia in elderly patients. J Am Geriatrics Soc. 47:(9):1999;S87.
6. American Psychiatric Association. Diagnostic and statisical manual of mental disorders. 4th ed :1994;American Psychiatric Association, Washington, DC.
7. Rechtschaffen A., Kales A. A manual of standardized terminology, techniques and scoring systems for sleep stages of human subjects. 1968;Brain Information Service/Brain Research Institute, Los Angeles, CA.
8. Mendelson W.B. Medications in the treatment of sleep disorders. Meltzer H.Y. Psychopharmacology: the third generation of progress. 1987;1305-1311 Raven Press, New York.
9. Roth T., Roehrs T. Issues in the use of benzodiazepine therapy. J Clin Psychiat. 53:1992;S14-S18.
10. Kales A., Soldatos C.R., Bixler E.O., Kales J.D. Early morning insomnia with rapidly eliminated benzodiazepines. Science. 220:1983;95-97.
11. Walsh J.K., Pollak C.P., Scharf M.B., Schweitzer P.K., et al. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia. Clin Neuropharm. 2000;. (in press).
12. Danjou P., Paty I., Fruncillo R., Worthington P., et al. A comparison of the residual effects of zaleplon and zolpidem following administration five to two hours before awakening. Br J Clin Phamacol. 48:1999;367-374.
13. Greenblatt D.J., Harmatz J.S., von Moltke L.L., Ehrenberg B.L., et al. Comparative kinetics and dynamics of zaleplon, zolpidem and placebo. Clin Pharmacol Ther. 64:1998;553561.
14. Scharf M.B., Roth T., Vogel G.W., Walsh J.K. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiat. 55:1994;192-199.
15. Monti J.M., Attali P., Monti D., Zipfel A., et al. Zolpidem and rebound insomnia-a double-blind, controlled polysomnographic study in chronic insomnia patients. Pharmacopsychiatry. 27:1994;166-175.
16. Oswald I., French C., Adam K., Gilham J. Benzodiazepine hypnotics remain effective for 24 weeks. Br Med J. 284:1982;860-863.
17. Leibowitz M., Sunshine A. Long-term hypnotic efficacy and safety of triazolam and flurazepam. J Clin Pharmacol. 18:1978;302-309.
18. Pierce M.W., Shu V.S. Efficacy of estazolam: the United States clinical experience. Am J Med. 88:(Suppl 3A):1990;65-115.
19. Kummer J., Guendel L., Linden J., Eich F.X., et al. Long-term polysomnographic study of the efficacy and safety of zolpidem in elderly psychiatric in-patients with insomnia. J Int Med Res. 21:1993;171-184.